期刊文献+

nm23蛋白在膀胱癌中的表达及其临床意义 被引量:1

Expression of nm23 Protein in Bladder Carcinoma
暂未订购
导出
摘要 目的:观察nm23基因在膀胱癌中的表达并探讨其临床意义。方法:对47例膀胱癌标本进行S-P免疫组化染色,分析nm23蛋白表达与膀胱癌多种指标和预后的关系。结果:nm23蛋白在膀胱癌组织及非癌粘膜中均有表达,定位于细胞浆。72.34%的膀胱癌组织nm23蛋白染色阳性,阳性率显著高于非癌粘膜(P<0.05)。nm23蛋白高度表达与膀胱癌细胞的低度分化及局部浸润有关,与肿瘤复发及肿瘤大小无关。结论:在膀胱癌中nm23基因可能不是转移抑制基因,相反却促进膀胱癌的发生和发展,nm23蛋白对于判断膀胱癌细胞的恶性程度、肿瘤进展以及预后有价值。 Objective: We studied the expression of nm23 protein in bladder carcinoma in order to evaluate its clinical significance. HZMethods: We studied the expression of nm23 protein in 47 cases of bladder carcinoma by the method of SP immunohistochemistry. The relationship between nm23 protein expression and several parameters and prognosis of bladder carcinoma were analyzed. Results: The expression of nm23 protein was detected in both bladder carcinoma tissue and noncarcinoma mucosa and the nm23 protein was located in cytoplasm. 72.34% of bladder carcinoma were positively stained; the positive rate was higher than that of noncarcinoma tissue (P<0.05). The high expression rate of nm23 protein was associated with poor differentiation and local infiltration, but it was not associated with age and sex of the patients as well as the tumor size. Conclusion: BZThe nm23 gene in bladder carcinoma could not be a metastasis suppressor gene, on the contrary, it could promote the genesis and progression of bladder might be of some value to judge the malignancy and progression together with prognosis.
出处 《中国医科大学学报》 CAS CSCD 北大核心 1999年第3期210-212,共3页 Journal of China Medical University
关键词 NM23蛋白 免疫组织化学 膀胱肿瘤 nm23 protein immunohistochemistry bladder neoplasmcarcinoma examination of nm23
  • 相关文献

同被引文献17

  • 1倪灿荣.抗转移癌基因-nm_(23)的生物学特征及肿瘤表达水平的意义[J].诊断病理学杂志,1995,2(4):235-236. 被引量:10
  • 2吴忠,张元芳,刘定干,李载平,贺斌.CD_(44)基因变异性表达与膀胱癌的关系[J].中华外科杂志,1996,34(11):645-647. 被引量:6
  • 3Sumantran VN, Ealovega MW, Nunez G, et al. Overexpression of bcl-x(s) sensitizes MCF-7 cells to chemotherapy induced apoptosis . Cancer Res, 1995,55:2507~10.
  • 4Haldar S,Basu A,Croce CM, et al . Bcl-2 is the guardian of microtubule integrity . Cancer Res , 1997 ,57:229~33.
  • 5Meyashita T,Krajewski S, Krajewski M, et al . Tumor suppressor p53 is a regulater of bcl-2 and bax gene in vitro and in vivo. Oncogene , 1994,9:1799~805.
  • 6Brambilla E , Negoescu A , Gazzeri S, et al . Apoptosis related factors p53 , bcl-2 and bax in neuroendocrine lung tumors . Am J Pathol , 1996 ,149:1941~52.
  • 7Bilim VN,Tomita Y,Kawasaki T, et al.Variable bcl-2 phenotype in benign and malignant lesions of urothelium. Cancer Lett, 1998,128(1):87~92.
  • 8Lipponen P,Aaltoma S,Kosma VM,et al .Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.J Pathol ,1998,186(2):157~64.
  • 9黄蓓,武忠弼,阮幼冰.人肝癌组织nm23的表达及其与转移的关系[J].临床与实验病理学杂志,1997,13(1):25-26. 被引量:8
  • 10符伟军,宋永胜,林国宏,崔秀娟,郭恩忠,严友农.促凋亡基因Bax在膀胱癌表达的免疫组化检测[J].中国医科大学学报,1998,27(2):178-180. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部